Upsher-Smith named 2024 ASAP Alliance Excellence Award finalist
Upsher-Smith has been named by The Association of Strategic Alliance Professionals as an ASAP Alliance Excellence Award finalist in two categories. ASAP recognized Upsher-Smith’s achievements in the individual long-standing alliance and individual company alliance excellence categories during the ASAP Global Alliance Summit in Cape Coral, Fla. Winners will be announced in a virtual ceremony on June 12.
The ASAP Alliance Excellence Awards are the alliance management community’s most prestigious honor and recognize outstanding contributions to strategic alliance management across a diverse array of industries. Upsher-Smith’s nomination underscores its commitment to effective alliance practices and its significant impact on business outcomes such as revenue growth, market expansion and product development.
“Strategic alliance management emerged as a key focus for us several years ago and allowed us to change our product development strategy,” said Rich Fisher, president and COO of Upsher-Smith. “In recent years, we have focused our efforts toward expanding our generics portfolio through high-impact partnerships. This nomination reaffirms our steadfast commitment to effective alliances. To be a finalist in these awards among the ranks of industry-leading pharmaceutical companies confirms it’s the right approach to grow our business.”
[Read more: Upsher-Smith extends fluoxetine product line]
In the Individual Long-Standing Alliance Category, Upsher-Smith was nominated for its decade-long partnership with New Zealand-based Douglas Pharmaceuticals. This alliance has facilitated mutual growth and innovation, resulting in increased efficiency and market competitiveness for both parties. Through shared objectives and continuous improvement initiatives, Upsher-Smith and Douglas have cultivated a collaborative culture and continue to improve efficiency, optimize ROI and assure a continuous supply of products to customers, the company said.
Upsher-Smith shared that its strategic approach to alliance management has yielded significant achievements in broadening its commercial portfolio and accessing specialized technical expertise, leading to being named a finalist in the individual company alliance excellence category. The company’s established strategic alliance practices and track record of successful specialty and generic pharmaceutical product launches have contributed to its growth and market positioning. By leveraging best practices and fostering strong relationships with alliance partners, Upsher-Smith has established a platform for growth and is positioned to better serve its customers.
[Read more: Upsher-Smith extends fluoxetine product line]